Tianjin Lisheng Pharmaceutical Co., Ltd. logo

Tianjin Lisheng Pharmaceutical Co., Ltd.

002393 · SZSE · China

lishengpharma.com

Financials as of FY2025

What stands out
  • Earnings significantly exceed cash generation
At a glance
  • Depends onMidstream position: 5 outgoing, 4 incoming connections
  • ScaleLevered free cash flow is $57.5M, above the global median of $18.58M
  • FinancialsAltman Z-Score 3.91: safe zone
  • Interpretations3 currently firing — 3